| Literature DB >> 2418902 |
H Reece Smith, A Memon, C J Smart, K Dewbury.
Abstract
A double-blind trial comparing the effect of Permixon (160 mg bd) against placebo in the treatment of benign prostatic hypertrophy is described. In both groups a significant improvement in flow rate and subjective assessment of symptoms was seen. There was no significant difference between the results of treatment in either group.Entities:
Mesh：
Substances：
Year: 1986 PMID： 2418902 DOI： 10.1111/j.1464-410x.1986.tb05424.x
Source DB: PubMed Journal: Br J Urol ISSN： 0007-1331